Oliveira, L.G. et al. 2026. Pathologic complete response and efficacy with neoadjuvant anthracycline followed by paclitaxel, trastuzumab, and pertuzumab in patients with HER2-positive early breast cancer: A real-world experience of Brazil. Mastology. 33, suppl.1 (Mar. 2026). DOI:https://doi.org/10.29289/259453942023V33S1082.